 Jens Kuhn
Concepts (837)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Viruses | 48 | 2025 | 163 | 14.730 |
Why?
| | Genome, Viral | 81 | 2025 | 224 | 14.360 |
Why?
| | RNA Viruses | 33 | 2025 | 76 | 13.330 |
Why?
| | Ebolavirus | 54 | 2026 | 89 | 10.480 |
Why?
| | Hemorrhagic Fever, Ebola | 43 | 2026 | 79 | 8.130 |
Why?
| | Phylogeny | 87 | 2025 | 1003 | 8.000 |
Why?
| | Filoviridae | 22 | 2023 | 28 | 6.960 |
Why?
| | Terminology as Topic | 30 | 2025 | 248 | 5.510 |
Why?
| | Mononegavirales | 10 | 2022 | 10 | 5.200 |
Why?
| | Deep Brain Stimulation | 25 | 2025 | 196 | 4.910 |
Why?
| | Classification | 20 | 2025 | 43 | 4.140 |
Why?
| | Virus Replication | 41 | 2026 | 542 | 4.000 |
Why?
| | Arterivirus | 15 | 2024 | 18 | 3.740 |
Why?
| | Tourette Syndrome | 11 | 2025 | 23 | 3.530 |
Why?
| | RNA, Viral | 32 | 2024 | 702 | 3.430 |
Why?
| | Marburgvirus | 11 | 2024 | 21 | 3.040 |
Why?
| | Virion | 22 | 2025 | 114 | 2.850 |
Why?
| | Arenaviridae | 10 | 2024 | 12 | 2.830 |
Why?
| | Antiviral Agents | 17 | 2024 | 758 | 2.620 |
Why?
| | Arthropods | 4 | 2024 | 15 | 2.570 |
Why?
| | Viral Proteins | 21 | 2025 | 370 | 2.410 |
Why?
| | Animals | 166 | 2026 | 37697 | 2.410 |
Why?
| | Open Reading Frames | 10 | 2024 | 133 | 2.330 |
Why?
| | Hemorrhagic Fevers, Viral | 9 | 2022 | 16 | 2.280 |
Why?
| | Virus Internalization | 18 | 2022 | 64 | 2.180 |
Why?
| | Arterivirus Infections | 9 | 2019 | 10 | 2.160 |
Why?
| | Virology | 12 | 2025 | 36 | 2.120 |
Why?
| | Nucleoproteins | 10 | 2024 | 37 | 2.080 |
Why?
| | Obsessive-Compulsive Disorder | 8 | 2022 | 55 | 2.060 |
Why?
| | Flaviviridae | 4 | 2025 | 10 | 2.000 |
Why?
| | Ebola Vaccines | 9 | 2026 | 13 | 1.970 |
Why?
| | Arenaviridae Infections | 9 | 2024 | 17 | 1.950 |
Why?
| | Host-Pathogen Interactions | 16 | 2025 | 369 | 1.840 |
Why?
| | Filoviridae Infections | 5 | 2019 | 9 | 1.830 |
Why?
| | Rhabdoviridae | 4 | 2024 | 4 | 1.800 |
Why?
| | Viroids | 3 | 2024 | 6 | 1.750 |
Why?
| | Receptors, Virus | 11 | 2015 | 95 | 1.710 |
Why?
| | Antibodies, Viral | 17 | 2026 | 664 | 1.640 |
Why?
| | Bunyaviridae | 4 | 2024 | 4 | 1.620 |
Why?
| | DNA Viruses | 9 | 2025 | 23 | 1.620 |
Why?
| | Viral Vaccines | 9 | 2020 | 107 | 1.570 |
Why?
| | Monkey Diseases | 5 | 2020 | 25 | 1.530 |
Why?
| | Hemorrhagic Fever Virus, Crimean-Congo | 7 | 2023 | 12 | 1.480 |
Why?
| | Hemorrhagic Fever, Crimean | 6 | 2023 | 10 | 1.380 |
Why?
| | Wasps | 6 | 2024 | 23 | 1.340 |
Why?
| | Humans | 197 | 2026 | 142526 | 1.330 |
Why?
| | Evolution, Molecular | 13 | 2025 | 504 | 1.320 |
Why?
| | Containment of Biohazards | 8 | 2025 | 21 | 1.300 |
Why?
| | Disease Outbreaks | 20 | 2021 | 428 | 1.200 |
Why?
| | Chiroptera | 7 | 2021 | 60 | 1.190 |
Why?
| | Green Fluorescent Proteins | 3 | 2023 | 403 | 1.170 |
Why?
| | Nipah Virus | 3 | 2025 | 3 | 1.130 |
Why?
| | Lassa virus | 7 | 2023 | 8 | 1.120 |
Why?
| | Genetic Variation | 13 | 2020 | 999 | 1.110 |
Why?
| | Henipavirus Infections | 2 | 2025 | 2 | 1.110 |
Why?
| | Vero Cells | 18 | 2023 | 87 | 1.100 |
Why?
| | Viral Envelope Proteins | 12 | 2025 | 98 | 1.050 |
Why?
| | Connectome | 3 | 2024 | 91 | 1.040 |
Why?
| | Basal Nucleus of Meynert | 3 | 2017 | 4 | 1.030 |
Why?
| | Delay Discounting | 3 | 2023 | 29 | 1.020 |
Why?
| | Drug Evaluation, Preclinical | 5 | 2020 | 194 | 1.000 |
Why?
| | Macaca mulatta | 12 | 2025 | 191 | 0.990 |
Why?
| | RNA Virus Infections | 5 | 2018 | 20 | 0.990 |
Why?
| | Monkeypox virus | 4 | 2025 | 23 | 0.970 |
Why?
| | Animal Use Alternatives | 1 | 2025 | 1 | 0.960 |
Why?
| | Communicable Diseases, Emerging | 4 | 2022 | 39 | 0.950 |
Why?
| | Brain | 14 | 2025 | 2875 | 0.940 |
Why?
| | Coronavirus Infections | 8 | 2020 | 371 | 0.910 |
Why?
| | Pyrimidine Nucleosides | 2 | 2022 | 3 | 0.910 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2025 | 64 | 0.890 |
Why?
| | Glycoproteins | 13 | 2025 | 356 | 0.890 |
Why?
| | Nairovirus | 3 | 2024 | 3 | 0.880 |
Why?
| | Primates | 12 | 2023 | 132 | 0.870 |
Why?
| | Central Nervous System Viral Diseases | 1 | 2025 | 79 | 0.860 |
Why?
| | Genomics | 13 | 2024 | 820 | 0.860 |
Why?
| | Archaeal Viruses | 4 | 2025 | 12 | 0.860 |
Why?
| | Helper Viruses | 1 | 2024 | 3 | 0.850 |
Why?
| | DNA, Complementary | 4 | 2021 | 275 | 0.840 |
Why?
| | Organoids | 1 | 2025 | 130 | 0.830 |
Why?
| | Recombination, Genetic | 2 | 2024 | 205 | 0.830 |
Why?
| | Viral Core Proteins | 2 | 2020 | 22 | 0.830 |
Why?
| | Primate Diseases | 4 | 2018 | 8 | 0.820 |
Why?
| | Antibodies, Monoclonal | 7 | 2025 | 1471 | 0.820 |
Why?
| | Antigens, CD | 7 | 2023 | 545 | 0.810 |
Why?
| | Flavivirus | 1 | 2023 | 19 | 0.800 |
Why?
| | Cell Line | 21 | 2025 | 2878 | 0.790 |
Why?
| | Polydnaviridae | 1 | 2023 | 1 | 0.790 |
Why?
| | Rhabdoviridae Infections | 2 | 2020 | 2 | 0.780 |
Why?
| | Arteriviridae | 4 | 2018 | 4 | 0.780 |
Why?
| | Thalamus | 5 | 2025 | 115 | 0.770 |
Why?
| | Biomedical Research | 5 | 2014 | 692 | 0.770 |
Why?
| | Mammals | 6 | 2024 | 286 | 0.770 |
Why?
| | Databases, Nucleic Acid | 3 | 2023 | 39 | 0.760 |
Why?
| | Disease Reservoirs | 4 | 2017 | 25 | 0.750 |
Why?
| | Arenaviruses, New World | 6 | 2013 | 9 | 0.750 |
Why?
| | Antibodies, Neutralizing | 9 | 2025 | 327 | 0.730 |
Why?
| | Alzheimer Disease | 3 | 2017 | 603 | 0.710 |
Why?
| | Frontal Lobe | 3 | 2025 | 161 | 0.710 |
Why?
| | Clinical Deterioration | 1 | 2021 | 9 | 0.690 |
Why?
| | Macaca | 6 | 2025 | 65 | 0.680 |
Why?
| | Virus Diseases | 3 | 2020 | 218 | 0.680 |
Why?
| | Lassa Fever | 4 | 2023 | 5 | 0.680 |
Why?
| | Pan troglodytes | 2 | 2021 | 66 | 0.680 |
Why?
| | Parkinson Disease | 4 | 2022 | 574 | 0.680 |
Why?
| | Middle East Respiratory Syndrome Coronavirus | 3 | 2016 | 12 | 0.680 |
Why?
| | Post-Exposure Prophylaxis | 2 | 2020 | 13 | 0.670 |
Why?
| | Marburg Virus Disease | 4 | 2023 | 11 | 0.670 |
Why?
| | Picornaviridae | 1 | 2020 | 20 | 0.670 |
Why?
| | Impulsive Behavior | 2 | 2022 | 150 | 0.660 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 3 | 2023 | 66 | 0.660 |
Why?
| | Neutralization Tests | 3 | 2019 | 80 | 0.650 |
Why?
| | Symbiosis | 2 | 2024 | 82 | 0.640 |
Why?
| | Picornaviridae Infections | 1 | 2020 | 51 | 0.640 |
Why?
| | Biological Evolution | 7 | 2024 | 488 | 0.640 |
Why?
| | International Cooperation | 3 | 2021 | 195 | 0.640 |
Why?
| | Receptors, Transferrin | 4 | 2013 | 28 | 0.630 |
Why?
| | World Health Organization | 2 | 2021 | 103 | 0.630 |
Why?
| | Bornaviridae | 2 | 2021 | 2 | 0.630 |
Why?
| | Membrane Glycoproteins | 7 | 2015 | 496 | 0.610 |
Why?
| | Metagenomics | 8 | 2024 | 180 | 0.600 |
Why?
| | Staining and Labeling | 2 | 2020 | 152 | 0.600 |
Why?
| | Biodiversity | 2 | 2022 | 421 | 0.590 |
Why?
| | Luminescent Agents | 1 | 2018 | 8 | 0.590 |
Why?
| | Antipsychotic Agents | 1 | 2021 | 210 | 0.590 |
Why?
| | Receptors, Cell Surface | 4 | 2023 | 376 | 0.590 |
Why?
| | Corpus Striatum | 1 | 2020 | 178 | 0.570 |
Why?
| | Genes, Reporter | 2 | 2018 | 271 | 0.570 |
Why?
| | Reverse Transcription | 1 | 2018 | 20 | 0.570 |
Why?
| | Sequence Analysis, DNA | 13 | 2017 | 820 | 0.570 |
Why?
| | Macaca fascicularis | 3 | 2021 | 69 | 0.560 |
Why?
| | Hantavirus Pulmonary Syndrome | 3 | 2023 | 5 | 0.550 |
Why?
| | Influenza A virus | 4 | 2025 | 112 | 0.550 |
Why?
| | Evoked Potentials | 2 | 2018 | 131 | 0.550 |
Why?
| | Host Specificity | 7 | 2025 | 35 | 0.540 |
Why?
| | Archaea | 3 | 2025 | 84 | 0.540 |
Why?
| | Amino Acid Sequence | 16 | 2020 | 2150 | 0.540 |
Why?
| | Disease Models, Animal | 16 | 2026 | 4483 | 0.540 |
Why?
| | Hospitals, Psychiatric | 2 | 2026 | 28 | 0.530 |
Why?
| | Nucleus Accumbens | 9 | 2023 | 151 | 0.520 |
Why?
| | Reaction Time | 2 | 2018 | 433 | 0.510 |
Why?
| | Bird Diseases | 2 | 2016 | 16 | 0.510 |
Why?
| | High-Throughput Nucleotide Sequencing | 8 | 2020 | 546 | 0.510 |
Why?
| | Societies, Scientific | 2 | 2017 | 50 | 0.500 |
Why?
| | Male | 56 | 2026 | 70910 | 0.500 |
Why?
| | Endocytosis | 2 | 2014 | 169 | 0.500 |
Why?
| | Reverse Genetics | 4 | 2021 | 7 | 0.500 |
Why?
| | Cognitive Dysfunction | 1 | 2022 | 429 | 0.500 |
Why?
| | Neglected Diseases | 1 | 2016 | 5 | 0.500 |
Why?
| | Borna Disease | 2 | 2021 | 2 | 0.490 |
Why?
| | Colobus | 1 | 2016 | 3 | 0.490 |
Why?
| | Retroviridae | 4 | 2025 | 103 | 0.490 |
Why?
| | Dogs | 2 | 2015 | 426 | 0.480 |
Why?
| | Dipeptidyl Peptidase 4 | 2 | 2016 | 15 | 0.470 |
Why?
| | HEK293 Cells | 11 | 2025 | 747 | 0.470 |
Why?
| | Laboratories | 4 | 2016 | 106 | 0.470 |
Why?
| | Animal Assisted Therapy | 1 | 2015 | 12 | 0.470 |
Why?
| | Africa | 8 | 2021 | 113 | 0.470 |
Why?
| | Psychomotor Performance | 1 | 2018 | 328 | 0.460 |
Why?
| | Hospitals, University | 1 | 2015 | 176 | 0.450 |
Why?
| | Ticks | 5 | 2023 | 29 | 0.450 |
Why?
| | Reflex, Startle | 2 | 2020 | 72 | 0.450 |
Why?
| | Communicable Diseases | 2 | 2014 | 165 | 0.450 |
Why?
| | Insecta | 3 | 2024 | 73 | 0.440 |
Why?
| | Nematoda | 2 | 2017 | 11 | 0.430 |
Why?
| | Female | 51 | 2026 | 76624 | 0.430 |
Why?
| | Tic Disorders | 1 | 2014 | 8 | 0.430 |
Why?
| | Asymptomatic Infections | 4 | 2018 | 37 | 0.430 |
Why?
| | Depressive Disorder | 2 | 2015 | 376 | 0.430 |
Why?
| | Plant Viruses | 3 | 2025 | 11 | 0.420 |
Why?
| | Reassortant Viruses | 1 | 2013 | 8 | 0.410 |
Why?
| | Virus Release | 5 | 2020 | 8 | 0.410 |
Why?
| | Molecular Sequence Data | 16 | 2015 | 2916 | 0.410 |
Why?
| | Communicable Disease Control | 1 | 2014 | 86 | 0.410 |
Why?
| | Aerosols | 5 | 2026 | 179 | 0.400 |
Why?
| | Cluster Analysis | 9 | 2019 | 522 | 0.400 |
Why?
| | Viral Load | 6 | 2020 | 511 | 0.400 |
Why?
| | Cricetinae | 6 | 2026 | 299 | 0.400 |
Why?
| | Mesocricetus | 5 | 2026 | 46 | 0.400 |
Why?
| | Positron Emission Tomography Computed Tomography | 2 | 2026 | 116 | 0.390 |
Why?
| | Animals, Laboratory | 1 | 2013 | 19 | 0.390 |
Why?
| | Magnetic Resonance Imaging | 8 | 2025 | 3776 | 0.390 |
Why?
| | Treatment Outcome | 13 | 2023 | 11298 | 0.380 |
Why?
| | Infectious bronchitis virus | 3 | 2017 | 3 | 0.370 |
Why?
| | Zoonoses | 4 | 2022 | 36 | 0.370 |
Why?
| | Suicide, Attempted | 2 | 2026 | 396 | 0.370 |
Why?
| | Viruses, Unclassified | 2 | 2022 | 4 | 0.370 |
Why?
| | Bioterrorism | 1 | 2011 | 31 | 0.360 |
Why?
| | Capsid Proteins | 4 | 2025 | 98 | 0.350 |
Why?
| | Safety | 4 | 2016 | 356 | 0.350 |
Why?
| | Peptidyl-Dipeptidase A | 4 | 2007 | 55 | 0.350 |
Why?
| | Occupational Health | 1 | 2014 | 203 | 0.350 |
Why?
| | Autistic Disorder | 1 | 2014 | 211 | 0.340 |
Why?
| | Specimen Handling | 3 | 2025 | 181 | 0.340 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2011 | 43 | 0.340 |
Why?
| | Immunoglobulin G | 4 | 2026 | 893 | 0.340 |
Why?
| | Internal Capsule | 5 | 2022 | 7 | 0.330 |
Why?
| | Sequence Alignment | 7 | 2020 | 365 | 0.330 |
Why?
| | Viral Tropism | 3 | 2026 | 36 | 0.330 |
Why?
| | Bacteriophages | 3 | 2023 | 108 | 0.320 |
Why?
| | Animals, Wild | 4 | 2020 | 62 | 0.320 |
Why?
| | Neuroimaging | 2 | 2025 | 279 | 0.320 |
Why?
| | Neural Pathways | 3 | 2025 | 305 | 0.320 |
Why?
| | Plasmids | 2 | 2021 | 369 | 0.320 |
Why?
| | Suicidal Ideation | 2 | 2026 | 552 | 0.320 |
Why?
| | Beta Rhythm | 2 | 2024 | 30 | 0.320 |
Why?
| | Guinea Pigs | 8 | 2026 | 162 | 0.320 |
Why?
| | Nervous System Diseases | 2 | 2010 | 280 | 0.310 |
Why?
| | Adult | 26 | 2026 | 39715 | 0.310 |
Why?
| | Sequence Homology | 4 | 2017 | 43 | 0.310 |
Why?
| | Vaccination | 6 | 2026 | 1479 | 0.300 |
Why?
| | Animal Diseases | 2 | 2022 | 8 | 0.300 |
Why?
| | Genotype | 6 | 2022 | 1866 | 0.300 |
Why?
| | RNA | 5 | 2023 | 929 | 0.300 |
Why?
| | Virulence | 4 | 2024 | 271 | 0.300 |
Why?
| | Mental Disorders | 2 | 2026 | 1144 | 0.290 |
Why?
| | Neuropsychological Tests | 4 | 2021 | 1096 | 0.290 |
Why?
| | Young Adult | 12 | 2026 | 13878 | 0.290 |
Why?
| | Pandemics | 5 | 2021 | 1661 | 0.290 |
Why?
| | Electroencephalography | 6 | 2025 | 531 | 0.290 |
Why?
| | Mice | 18 | 2025 | 18172 | 0.290 |
Why?
| | Antidepressive Agents | 2 | 2021 | 243 | 0.280 |
Why?
| | Pick Disease of the Brain | 1 | 2007 | 4 | 0.270 |
Why?
| | Africa, Western | 4 | 2020 | 21 | 0.270 |
Why?
| | Middle Aged | 21 | 2026 | 35049 | 0.270 |
Why?
| | Bayes Theorem | 4 | 2023 | 424 | 0.260 |
Why?
| | Positron-Emission Tomography | 3 | 2022 | 309 | 0.260 |
Why?
| | Tics | 2 | 2024 | 4 | 0.260 |
Why?
| | Psychiatric Status Rating Scales | 4 | 2017 | 553 | 0.250 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2018 | 391 | 0.250 |
Why?
| | National Institute of Allergy and Infectious Diseases (U.S.) | 4 | 2014 | 25 | 0.250 |
Why?
| | Depressive Disorder, Treatment-Resistant | 2 | 2017 | 13 | 0.250 |
Why?
| | Virus Cultivation | 2 | 2018 | 31 | 0.250 |
Why?
| | Whole Genome Sequencing | 4 | 2025 | 175 | 0.250 |
Why?
| | Aotidae | 1 | 2026 | 10 | 0.240 |
Why?
| | Gyrus Cinguli | 2 | 2017 | 93 | 0.240 |
Why?
| | Subthalamic Nucleus | 3 | 2020 | 83 | 0.240 |
Why?
| | DNA, Viral | 4 | 2025 | 364 | 0.240 |
Why?
| | ADP-Ribosylation | 1 | 2025 | 1 | 0.240 |
Why?
| | Viremia | 2 | 2025 | 156 | 0.240 |
Why?
| | Rumination, Cognitive | 1 | 2026 | 12 | 0.240 |
Why?
| | Replicon | 1 | 2025 | 15 | 0.240 |
Why?
| | Toxicity Tests | 2 | 2016 | 39 | 0.240 |
Why?
| | Metacognition | 1 | 2026 | 17 | 0.240 |
Why?
| | Species Specificity | 2 | 2017 | 574 | 0.240 |
Why?
| | Adult Survivors of Child Abuse | 1 | 2026 | 29 | 0.240 |
Why?
| | Fluorodeoxyglucose F18 | 2 | 2026 | 151 | 0.230 |
Why?
| | Receptors, CXCR4 | 1 | 2026 | 91 | 0.230 |
Why?
| | RNA Helicases | 1 | 2025 | 32 | 0.230 |
Why?
| | Nucleocapsid Proteins | 3 | 2020 | 27 | 0.230 |
Why?
| | Germany | 4 | 2020 | 134 | 0.230 |
Why?
| | Nerve Net | 4 | 2025 | 276 | 0.230 |
Why?
| | Poly (ADP-Ribose) Polymerase-1 | 1 | 2025 | 54 | 0.230 |
Why?
| | Dengue Virus | 1 | 2025 | 55 | 0.230 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 375 | 0.230 |
Why?
| | Genes, Viral | 3 | 2020 | 92 | 0.230 |
Why?
| | Virus Inactivation | 1 | 2025 | 14 | 0.230 |
Why?
| | Schizophrenia | 2 | 2019 | 441 | 0.220 |
Why?
| | Clinical Laboratory Techniques | 3 | 2020 | 96 | 0.220 |
Why?
| | Respiratory System | 1 | 2026 | 156 | 0.220 |
Why?
| | Immunity, Humoral | 1 | 2025 | 117 | 0.220 |
Why?
| | Fungal Viruses | 1 | 2024 | 1 | 0.220 |
Why?
| | Liberia | 6 | 2025 | 15 | 0.220 |
Why?
| | Poxviridae | 1 | 2024 | 3 | 0.220 |
Why?
| | Orthopoxvirus | 1 | 2024 | 4 | 0.210 |
Why?
| | Tenuivirus | 1 | 2024 | 1 | 0.210 |
Why?
| | Hemiptera | 1 | 2024 | 4 | 0.210 |
Why?
| | Drug Discovery | 3 | 2015 | 148 | 0.210 |
Why?
| | Immunization, Secondary | 1 | 2024 | 92 | 0.210 |
Why?
| | CRISPR-Cas Systems | 1 | 2025 | 158 | 0.210 |
Why?
| | Ficus | 1 | 2024 | 2 | 0.210 |
Why?
| | Rodentia | 2 | 2021 | 59 | 0.210 |
Why?
| | History, 20th Century | 5 | 2020 | 327 | 0.210 |
Why?
| | One Health | 2 | 2021 | 11 | 0.210 |
Why?
| | Adolescent | 11 | 2026 | 22326 | 0.210 |
Why?
| | Oryza | 1 | 2024 | 29 | 0.210 |
Why?
| | Proof of Concept Study | 2 | 2021 | 84 | 0.210 |
Why?
| | Lactate dehydrogenase-elevating virus | 1 | 2023 | 1 | 0.210 |
Why?
| | Ectopic Gene Expression | 1 | 2023 | 5 | 0.210 |
Why?
| | Crustacea | 1 | 2023 | 5 | 0.210 |
Why?
| | Base Sequence | 6 | 2017 | 2176 | 0.210 |
Why?
| | Models, Molecular | 9 | 2024 | 1616 | 0.210 |
Why?
| | Dementia | 1 | 2007 | 281 | 0.200 |
Why?
| | Immunohistochemistry | 4 | 2020 | 1727 | 0.200 |
Why?
| | Quality of Life | 6 | 2023 | 3064 | 0.200 |
Why?
| | DNA Transposable Elements | 1 | 2024 | 120 | 0.200 |
Why?
| | Uganda | 3 | 2020 | 88 | 0.200 |
Why?
| | Drug Design | 1 | 2024 | 172 | 0.200 |
Why?
| | Public Health Surveillance | 2 | 2021 | 83 | 0.200 |
Why?
| | Gene Expression Regulation, Viral | 2 | 2020 | 100 | 0.190 |
Why?
| | Disinfectants | 1 | 2023 | 47 | 0.190 |
Why?
| | Biological Products | 2 | 2020 | 243 | 0.190 |
Why?
| | Electrodes, Implanted | 2 | 2020 | 113 | 0.190 |
Why?
| | Frameshifting, Ribosomal | 2 | 2019 | 9 | 0.190 |
Why?
| | Fungi | 1 | 2024 | 155 | 0.190 |
Why?
| | Vaccines, Attenuated | 2 | 2020 | 130 | 0.190 |
Why?
| | Cytopathogenic Effect, Viral | 2 | 2020 | 16 | 0.190 |
Why?
| | Plankton | 1 | 2022 | 7 | 0.190 |
Why?
| | Cell Culture Techniques | 2 | 2023 | 372 | 0.190 |
Why?
| | Democratic Republic of the Congo | 3 | 2019 | 33 | 0.190 |
Why?
| | Seawater | 1 | 2022 | 31 | 0.190 |
Why?
| | Virus Physiological Phenomena | 2 | 2020 | 8 | 0.190 |
Why?
| | Viral Plaque Assay | 2 | 2025 | 34 | 0.180 |
Why?
| | Antigens, Differentiation | 2 | 2013 | 78 | 0.180 |
Why?
| | Cowpox virus | 1 | 2021 | 2 | 0.180 |
Why?
| | HIV-1 | 3 | 2026 | 890 | 0.180 |
Why?
| | Fish Diseases | 1 | 2021 | 17 | 0.180 |
Why?
| | Borna disease virus | 1 | 2021 | 1 | 0.180 |
Why?
| | Hepacivirus | 1 | 2023 | 242 | 0.180 |
Why?
| | Smallpox | 1 | 2021 | 10 | 0.180 |
Why?
| | Ribavirin | 2 | 2020 | 82 | 0.180 |
Why?
| | Dicistroviridae | 1 | 2021 | 7 | 0.180 |
Why?
| | Proteome | 2 | 2018 | 491 | 0.170 |
Why?
| | Lymphocytic choriomeningitis virus | 2 | 2019 | 33 | 0.170 |
Why?
| | Sarcina | 1 | 2021 | 1 | 0.170 |
Why?
| | Uveitis | 1 | 2022 | 148 | 0.170 |
Why?
| | Fluvoxamine | 1 | 2021 | 16 | 0.170 |
Why?
| | Papio | 2 | 2018 | 92 | 0.170 |
Why?
| | Ape Diseases | 1 | 2021 | 7 | 0.170 |
Why?
| | Plant Diseases | 2 | 2024 | 41 | 0.170 |
Why?
| | Addiction Medicine | 1 | 2021 | 11 | 0.170 |
Why?
| | RNA, Small Interfering | 4 | 2016 | 629 | 0.170 |
Why?
| | Rubella virus | 1 | 2020 | 9 | 0.170 |
Why?
| | Phlebovirus | 1 | 2020 | 6 | 0.170 |
Why?
| | Anti-Infective Agents | 1 | 2023 | 243 | 0.170 |
Why?
| | Clinical Trials as Topic | 2 | 2016 | 1037 | 0.170 |
Why?
| | Immunotoxins | 1 | 2021 | 55 | 0.160 |
Why?
| | DNA Replication | 2 | 2020 | 245 | 0.160 |
Why?
| | Laboratory Infection | 1 | 2020 | 2 | 0.160 |
Why?
| | Betacoronavirus | 2 | 2020 | 278 | 0.160 |
Why?
| | Bunyaviridae Infections | 1 | 2020 | 15 | 0.160 |
Why?
| | Mutation | 9 | 2025 | 4024 | 0.160 |
Why?
| | Carrier State | 2 | 2020 | 75 | 0.160 |
Why?
| | DNA, Circular | 1 | 2020 | 15 | 0.160 |
Why?
| | Reward | 2 | 2020 | 252 | 0.160 |
Why?
| | RNA Polymerase II | 1 | 2024 | 341 | 0.160 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 1 | 2020 | 26 | 0.160 |
Why?
| | Myocarditis | 1 | 2021 | 99 | 0.160 |
Why?
| | Hominidae | 1 | 2021 | 86 | 0.160 |
Why?
| | Semen | 2 | 2021 | 21 | 0.160 |
Why?
| | Caudovirales | 1 | 2020 | 1 | 0.160 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2021 | 69 | 0.160 |
Why?
| | Cell Line, Tumor | 4 | 2022 | 3546 | 0.160 |
Why?
| | DNA, Intergenic | 1 | 2020 | 29 | 0.160 |
Why?
| | Child Abuse | 1 | 2026 | 549 | 0.160 |
Why?
| | Eukaryota | 3 | 2025 | 60 | 0.160 |
Why?
| | Arenavirus | 2 | 2020 | 2 | 0.160 |
Why?
| | Liver Diseases | 1 | 2023 | 304 | 0.160 |
Why?
| | Emphysema | 1 | 2021 | 113 | 0.160 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2017 | 985 | 0.160 |
Why?
| | Sequence Analysis, RNA | 3 | 2018 | 445 | 0.160 |
Why?
| | Porcine respiratory and reproductive syndrome virus | 1 | 2019 | 1 | 0.160 |
Why?
| | Gastritis | 1 | 2021 | 115 | 0.160 |
Why?
| | In Situ Hybridization | 2 | 2020 | 319 | 0.150 |
Why?
| | Databases, Pharmaceutical | 1 | 2019 | 5 | 0.150 |
Why?
| | Respiration | 2 | 2018 | 209 | 0.150 |
Why?
| | Inhalation Exposure | 2 | 2026 | 116 | 0.150 |
Why?
| | Fluorescent Antibody Technique | 1 | 2020 | 381 | 0.150 |
Why?
| | Molecular Structure | 1 | 2020 | 503 | 0.150 |
Why?
| | A549 Cells | 4 | 2020 | 74 | 0.150 |
Why?
| | Influenza, Human | 1 | 2025 | 635 | 0.150 |
Why?
| | Drug Repositioning | 1 | 2019 | 40 | 0.150 |
Why?
| | Internationality | 3 | 2017 | 156 | 0.150 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2020 | 2053 | 0.150 |
Why?
| | DNA, Single-Stranded | 1 | 2020 | 119 | 0.150 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 5 | 2025 | 853 | 0.150 |
Why?
| | Follow-Up Studies | 6 | 2020 | 5270 | 0.150 |
Why?
| | Guinea | 2 | 2018 | 3 | 0.150 |
Why?
| | Neuronavigation | 1 | 2019 | 8 | 0.150 |
Why?
| | Gene Rearrangement | 1 | 2020 | 149 | 0.150 |
Why?
| | Ixodidae | 1 | 2019 | 7 | 0.150 |
Why?
| | Phage Therapy | 1 | 2019 | 17 | 0.150 |
Why?
| | Fluorometry | 1 | 2018 | 18 | 0.150 |
Why?
| | Tiletamine | 1 | 2018 | 2 | 0.150 |
Why?
| | Zolazepam | 1 | 2018 | 2 | 0.150 |
Why?
| | Shrews | 1 | 2018 | 3 | 0.140 |
Why?
| | Hepadnaviridae | 1 | 2018 | 1 | 0.140 |
Why?
| | Caulimoviridae | 1 | 2018 | 1 | 0.140 |
Why?
| | Immobilization | 1 | 2018 | 47 | 0.140 |
Why?
| | Cerebral Cortex | 2 | 2024 | 463 | 0.140 |
Why?
| | Mononegavirales Infections | 1 | 2018 | 1 | 0.140 |
Why?
| | Cell Survival | 1 | 2022 | 1130 | 0.140 |
Why?
| | Time Factors | 5 | 2026 | 7006 | 0.140 |
Why?
| | Midazolam | 1 | 2018 | 72 | 0.140 |
Why?
| | Schizophrenic Psychology | 1 | 2018 | 97 | 0.140 |
Why?
| | Models, Neurological | 1 | 2020 | 248 | 0.140 |
Why?
| | Boidae | 1 | 2018 | 23 | 0.140 |
Why?
| | Spumavirus | 1 | 2018 | 3 | 0.140 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2020 | 144 | 0.140 |
Why?
| | Genomic Instability | 1 | 2018 | 59 | 0.140 |
Why?
| | Cell Membrane | 2 | 2020 | 706 | 0.140 |
Why?
| | Double-Blind Method | 4 | 2026 | 2007 | 0.140 |
Why?
| | Severe Acute Respiratory Syndrome | 3 | 2007 | 19 | 0.140 |
Why?
| | Committee Membership | 3 | 2023 | 5 | 0.140 |
Why?
| | Encephalomyocarditis virus | 1 | 2017 | 1 | 0.140 |
Why?
| | Papio hamadryas | 1 | 2017 | 3 | 0.140 |
Why?
| | Cardiovirus Infections | 1 | 2017 | 3 | 0.140 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2018 | 22 | 0.140 |
Why?
| | Protein Interaction Maps | 1 | 2018 | 49 | 0.140 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2018 | 55 | 0.140 |
Why?
| | Testis | 1 | 2018 | 158 | 0.140 |
Why?
| | Motivational Interviewing | 1 | 2019 | 118 | 0.140 |
Why?
| | Retroviridae Infections | 1 | 2018 | 48 | 0.140 |
Why?
| | Amino Acids | 2 | 2020 | 505 | 0.140 |
Why?
| | Protein Processing, Post-Translational | 2 | 2025 | 468 | 0.140 |
Why?
| | Biotechnology | 1 | 2018 | 45 | 0.130 |
Why?
| | Models, Theoretical | 1 | 2021 | 585 | 0.130 |
Why?
| | Software Design | 1 | 2017 | 25 | 0.130 |
Why?
| | MicroRNAs | 1 | 2024 | 696 | 0.130 |
Why?
| | Maryland | 2 | 2014 | 60 | 0.130 |
Why?
| | Gene Order | 1 | 2017 | 27 | 0.130 |
Why?
| | Outpatients | 1 | 2021 | 425 | 0.130 |
Why?
| | Acoustic Stimulation | 2 | 2020 | 325 | 0.130 |
Why?
| | Poultry Diseases | 1 | 2017 | 13 | 0.130 |
Why?
| | Diptera | 1 | 2017 | 31 | 0.130 |
Why?
| | Spike Glycoprotein, Coronavirus | 5 | 2017 | 125 | 0.130 |
Why?
| | Dopamine | 1 | 2020 | 305 | 0.130 |
Why?
| | Birds | 2 | 2017 | 92 | 0.130 |
Why?
| | Encephalitis Virus, Venezuelan Equine | 1 | 2016 | 6 | 0.130 |
Why?
| | Flaviviridae Infections | 1 | 2016 | 2 | 0.130 |
Why?
| | Tomography, X-Ray Computed | 4 | 2023 | 2771 | 0.130 |
Why?
| | Enzyme Inhibitors | 1 | 2020 | 837 | 0.130 |
Why?
| | Zika Virus | 1 | 2018 | 132 | 0.130 |
Why?
| | Gene Regulatory Networks | 1 | 2019 | 315 | 0.130 |
Why?
| | Protective Clothing | 1 | 2016 | 16 | 0.130 |
Why?
| | Lentivirus Infections | 1 | 2016 | 9 | 0.130 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2016 | 38 | 0.120 |
Why?
| | Plethysmography | 1 | 2016 | 108 | 0.120 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2019 | 440 | 0.120 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2020 | 771 | 0.120 |
Why?
| | Vaccines | 1 | 2022 | 409 | 0.120 |
Why?
| | Polymerase Chain Reaction | 2 | 2017 | 1051 | 0.120 |
Why?
| | Electrophoresis, Agar Gel | 1 | 2016 | 25 | 0.120 |
Why?
| | Viral Nonstructural Proteins | 3 | 2025 | 67 | 0.120 |
Why?
| | Extracellular Vesicles | 1 | 2018 | 160 | 0.120 |
Why?
| | Functional Laterality | 1 | 2017 | 242 | 0.120 |
Why?
| | Macrophages | 4 | 2024 | 1496 | 0.120 |
Why?
| | Alphavirus | 1 | 2016 | 22 | 0.120 |
Why?
| | Chromosomes, Mammalian | 1 | 2016 | 28 | 0.120 |
Why?
| | Selection, Genetic | 2 | 2017 | 263 | 0.120 |
Why?
| | Hemorrhage | 1 | 2021 | 798 | 0.120 |
Why?
| | Virus Attachment | 1 | 2015 | 18 | 0.120 |
Why?
| | Immunoassay | 1 | 2016 | 110 | 0.120 |
Why?
| | Satellite Viruses | 1 | 2015 | 1 | 0.120 |
Why?
| | Orthobunyavirus | 1 | 2015 | 8 | 0.120 |
Why?
| | Alcoholism | 1 | 2023 | 834 | 0.120 |
Why?
| | Heat-Shock Proteins | 1 | 2016 | 140 | 0.120 |
Why?
| | Zika Virus Infection | 1 | 2018 | 169 | 0.120 |
Why?
| | Protein Binding | 7 | 2018 | 2249 | 0.120 |
Why?
| | Alphavirus Infections | 1 | 2016 | 45 | 0.120 |
Why?
| | Learning | 1 | 2020 | 434 | 0.120 |
Why?
| | Italy | 2 | 2025 | 110 | 0.120 |
Why?
| | Cell Cycle | 1 | 2018 | 610 | 0.120 |
Why?
| | Ecological Momentary Assessment | 2 | 2026 | 43 | 0.120 |
Why?
| | Plants | 3 | 2025 | 224 | 0.120 |
Why?
| | Immunization, Passive | 1 | 2015 | 88 | 0.120 |
Why?
| | Rabbits | 3 | 2020 | 664 | 0.110 |
Why?
| | Skin | 1 | 2020 | 769 | 0.110 |
Why?
| | Environmental Exposure | 1 | 2020 | 582 | 0.110 |
Why?
| | Carboxypeptidases | 2 | 2005 | 13 | 0.110 |
Why?
| | Immune Evasion | 1 | 2015 | 64 | 0.110 |
Why?
| | Epitopes | 3 | 2025 | 487 | 0.110 |
Why?
| | Cysteine Proteases | 1 | 2014 | 8 | 0.110 |
Why?
| | Feedback, Physiological | 1 | 2015 | 81 | 0.110 |
Why?
| | Aging | 1 | 2025 | 1931 | 0.110 |
Why?
| | Physician-Patient Relations | 1 | 2019 | 584 | 0.110 |
Why?
| | DNA | 1 | 2021 | 1447 | 0.110 |
Why?
| | RNA Interference | 2 | 2016 | 469 | 0.110 |
Why?
| | Substance-Related Disorders | 2 | 2021 | 1107 | 0.110 |
Why?
| | Computational Biology | 4 | 2025 | 673 | 0.110 |
Why?
| | Veterinary Medicine | 1 | 2014 | 11 | 0.110 |
Why?
| | Animal Experimentation | 1 | 2014 | 8 | 0.110 |
Why?
| | Repressor Proteins | 1 | 2018 | 435 | 0.110 |
Why?
| | Aged | 8 | 2021 | 25117 | 0.110 |
Why?
| | Asia | 3 | 2023 | 67 | 0.110 |
Why?
| | Compulsive Behavior | 1 | 2014 | 9 | 0.110 |
Why?
| | Adaptation, Biological | 1 | 2014 | 53 | 0.110 |
Why?
| | Opioid-Related Disorders | 1 | 2022 | 574 | 0.100 |
Why?
| | Animals, Zoo | 3 | 2020 | 15 | 0.100 |
Why?
| | Dopamine Agonists | 1 | 2014 | 42 | 0.100 |
Why?
| | Forecasting | 1 | 2015 | 384 | 0.100 |
Why?
| | Optical Imaging | 1 | 2014 | 64 | 0.100 |
Why?
| | Endosomes | 2 | 2014 | 144 | 0.100 |
Why?
| | Habituation, Psychophysiologic | 1 | 2014 | 58 | 0.100 |
Why?
| | Clathrin-Coated Vesicles | 1 | 2013 | 5 | 0.100 |
Why?
| | Comorbidity | 2 | 2020 | 1678 | 0.100 |
Why?
| | Hepatocytes | 1 | 2014 | 217 | 0.100 |
Why?
| | Rift Valley fever virus | 1 | 2013 | 3 | 0.100 |
Why?
| | Molecular Epidemiology | 3 | 2020 | 72 | 0.100 |
Why?
| | Clathrin | 1 | 2013 | 26 | 0.100 |
Why?
| | Membrane Proteins | 2 | 2025 | 1160 | 0.100 |
Why?
| | Nucleic Acid Conformation | 1 | 2016 | 726 | 0.100 |
Why?
| | Psychometrics | 1 | 2017 | 737 | 0.100 |
Why?
| | DNA Mutational Analysis | 4 | 2017 | 398 | 0.100 |
Why?
| | Tissue Culture Techniques | 1 | 2013 | 82 | 0.100 |
Why?
| | United States | 6 | 2024 | 15447 | 0.100 |
Why?
| | Survivors | 3 | 2022 | 502 | 0.100 |
Why?
| | Empathy | 1 | 2015 | 177 | 0.100 |
Why?
| | Neural Inhibition | 1 | 2014 | 176 | 0.100 |
Why?
| | Perception | 1 | 2016 | 378 | 0.100 |
Why?
| | Disease Susceptibility | 1 | 2014 | 353 | 0.100 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2014 | 371 | 0.090 |
Why?
| | Prospective Studies | 3 | 2026 | 7862 | 0.090 |
Why?
| | Oceans and Seas | 2 | 2022 | 23 | 0.090 |
Why?
| | Virosomes | 1 | 2012 | 2 | 0.090 |
Why?
| | Self Concept | 1 | 2014 | 255 | 0.090 |
Why?
| | Protein Kinases | 1 | 2014 | 309 | 0.090 |
Why?
| | Emotions | 2 | 2015 | 580 | 0.090 |
Why?
| | Diagnostic Errors | 2 | 2017 | 176 | 0.090 |
Why?
| | Lung | 2 | 2023 | 4078 | 0.090 |
Why?
| | Cross Reactions | 1 | 2012 | 133 | 0.090 |
Why?
| | Global Health | 2 | 2021 | 387 | 0.090 |
Why?
| | Retrospective Studies | 8 | 2026 | 16626 | 0.090 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2014 | 436 | 0.090 |
Why?
| | Cell Movement | 1 | 2016 | 969 | 0.090 |
Why?
| | Liver | 2 | 2018 | 1848 | 0.080 |
Why?
| | HIV Infections | 1 | 2026 | 3003 | 0.080 |
Why?
| | Bipolar Disorder | 1 | 2014 | 277 | 0.080 |
Why?
| | Recombinant Fusion Proteins | 2 | 2011 | 672 | 0.080 |
Why?
| | Invertebrates | 2 | 2021 | 24 | 0.080 |
Why?
| | Carrier Proteins | 1 | 2014 | 743 | 0.080 |
Why?
| | Particle Size | 2 | 2026 | 404 | 0.080 |
Why?
| | Models, Animal | 2 | 2023 | 392 | 0.080 |
Why?
| | Cattle | 2 | 2016 | 988 | 0.080 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2021 | 2146 | 0.080 |
Why?
| | Prevalence | 4 | 2019 | 2817 | 0.080 |
Why?
| | Algorithms | 1 | 2017 | 1791 | 0.070 |
Why?
| | Viral Fusion Proteins | 1 | 2009 | 19 | 0.070 |
Why?
| | RNA-Binding Proteins | 1 | 2013 | 454 | 0.070 |
Why?
| | Fibroblasts | 1 | 2014 | 1033 | 0.070 |
Why?
| | Sierra Leone | 2 | 2021 | 3 | 0.070 |
Why?
| | Ceruloplasmin | 1 | 2008 | 10 | 0.070 |
Why?
| | Communication | 3 | 2021 | 949 | 0.070 |
Why?
| | Sensory Gating | 2 | 2020 | 45 | 0.070 |
Why?
| | Metal Metabolism, Inborn Errors | 1 | 2008 | 6 | 0.070 |
Why?
| | History, 21st Century | 3 | 2017 | 220 | 0.070 |
Why?
| | Protein Structure, Tertiary | 4 | 2014 | 861 | 0.070 |
Why?
| | Interferons | 2 | 2020 | 195 | 0.070 |
Why?
| | Up-Regulation | 2 | 2024 | 857 | 0.070 |
Why?
| | Child | 3 | 2026 | 22562 | 0.070 |
Why?
| | Virus Assembly | 2 | 2020 | 79 | 0.070 |
Why?
| | Binding Sites | 5 | 2011 | 1317 | 0.070 |
Why?
| | Rehabilitation, Vocational | 1 | 2007 | 3 | 0.070 |
Why?
| | Brain Mapping | 2 | 2025 | 534 | 0.070 |
Why?
| | Dominance, Cerebral | 1 | 2007 | 55 | 0.070 |
Why?
| | Amino Acid Motifs | 2 | 2019 | 224 | 0.070 |
Why?
| | Coronavirus 229E, Human | 1 | 2007 | 7 | 0.070 |
Why?
| | Recurrence | 2 | 2022 | 1111 | 0.070 |
Why?
| | Temporal Lobe | 1 | 2007 | 104 | 0.060 |
Why?
| | Atrophy | 1 | 2007 | 196 | 0.060 |
Why?
| | Morocco | 2 | 2017 | 2 | 0.060 |
Why?
| | Ecosystem | 2 | 2022 | 579 | 0.060 |
Why?
| | Russia | 3 | 2017 | 13 | 0.060 |
Why?
| | Bacteria | 2 | 2025 | 881 | 0.060 |
Why?
| | Science | 1 | 2007 | 52 | 0.060 |
Why?
| | Anxiety | 1 | 2014 | 1087 | 0.060 |
Why?
| | Cats | 1 | 2007 | 226 | 0.060 |
Why?
| | Memory Disorders | 1 | 2007 | 184 | 0.060 |
Why?
| | Case-Control Studies | 1 | 2014 | 3604 | 0.060 |
Why?
| | Adenosine Diphosphate Ribose | 1 | 2025 | 6 | 0.060 |
Why?
| | Haplorhini | 2 | 2016 | 51 | 0.060 |
Why?
| | Hexosyltransferases | 1 | 2025 | 6 | 0.060 |
Why?
| | Immunocompetence | 1 | 2026 | 47 | 0.060 |
Why?
| | Vaccines, Synthetic | 2 | 2020 | 139 | 0.060 |
Why?
| | Pyrimidines | 2 | 2020 | 519 | 0.060 |
Why?
| | Madin Darby Canine Kidney Cells | 1 | 2025 | 17 | 0.060 |
Why?
| | Jurkat Cells | 1 | 2006 | 118 | 0.060 |
Why?
| | Administration, Intranasal | 1 | 2026 | 93 | 0.060 |
Why?
| | Gene Expression Regulation | 2 | 2014 | 2608 | 0.060 |
Why?
| | Alpha Rhythm | 1 | 2025 | 11 | 0.060 |
Why?
| | Vesiculovirus | 1 | 2025 | 17 | 0.060 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2025 | 34 | 0.060 |
Why?
| | Research Personnel | 1 | 2007 | 177 | 0.060 |
Why?
| | CD4 Antigens | 1 | 2026 | 146 | 0.060 |
Why?
| | Microscopy, Electron, Transmission | 2 | 2017 | 156 | 0.060 |
Why?
| | Comprehension | 1 | 2007 | 183 | 0.060 |
Why?
| | Caregivers | 1 | 2014 | 954 | 0.060 |
Why?
| | Hospitalization | 1 | 2015 | 2293 | 0.060 |
Why?
| | Chickens | 2 | 2016 | 189 | 0.060 |
Why?
| | Gene Knockout Techniques | 1 | 2025 | 117 | 0.060 |
Why?
| | Radiopharmaceuticals | 1 | 2026 | 191 | 0.060 |
Why?
| | Peptides | 1 | 2011 | 974 | 0.060 |
Why?
| | Coronaviridae | 1 | 2024 | 4 | 0.060 |
Why?
| | Ribonucleoproteins | 2 | 2019 | 103 | 0.060 |
Why?
| | Phylogeography | 2 | 2015 | 58 | 0.060 |
Why?
| | Gray Matter | 1 | 2025 | 87 | 0.060 |
Why?
| | Leukemia Virus, Murine | 1 | 2004 | 18 | 0.060 |
Why?
| | Immunogenicity, Vaccine | 1 | 2024 | 34 | 0.050 |
Why?
| | Combined Modality Therapy | 1 | 2007 | 1247 | 0.050 |
Why?
| | Fibrillin-2 | 1 | 2024 | 2 | 0.050 |
Why?
| | Chikungunya virus | 1 | 2025 | 87 | 0.050 |
Why?
| | Administration, Inhalation | 2 | 2016 | 596 | 0.050 |
Why?
| | DNA-Directed DNA Polymerase | 1 | 2024 | 48 | 0.050 |
Why?
| | Virus Integration | 1 | 2024 | 70 | 0.050 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2004 | 92 | 0.050 |
Why?
| | Attention | 1 | 2007 | 454 | 0.050 |
Why?
| | Immunity, Cellular | 2 | 2018 | 267 | 0.050 |
Why?
| | Heart | 2 | 2018 | 627 | 0.050 |
Why?
| | Cryoelectron Microscopy | 1 | 2025 | 207 | 0.050 |
Why?
| | Pollination | 1 | 2024 | 24 | 0.050 |
Why?
| | Antibody Formation | 1 | 2024 | 297 | 0.050 |
Why?
| | Disease Progression | 2 | 2023 | 2831 | 0.050 |
Why?
| | Crystallography, X-Ray | 1 | 2025 | 487 | 0.050 |
Why?
| | Canada | 1 | 2024 | 428 | 0.050 |
Why?
| | Anhedonia | 1 | 2023 | 16 | 0.050 |
Why?
| | Fruit | 1 | 2024 | 146 | 0.050 |
Why?
| | Anesthesia | 2 | 2016 | 250 | 0.050 |
Why?
| | Ecology | 1 | 2024 | 119 | 0.050 |
Why?
| | Glycosylation | 2 | 2016 | 169 | 0.050 |
Why?
| | Carbon Cycle | 1 | 2022 | 13 | 0.050 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2006 | 403 | 0.050 |
Why?
| | Reproducibility of Results | 2 | 2023 | 3362 | 0.050 |
Why?
| | Livestock | 1 | 2022 | 11 | 0.050 |
Why?
| | Analysis of Variance | 2 | 2016 | 1313 | 0.050 |
Why?
| | Switzerland | 1 | 2021 | 42 | 0.050 |
Why?
| | Lymphocyte Count | 1 | 2022 | 167 | 0.040 |
Why?
| | Fresh Water | 1 | 2021 | 57 | 0.040 |
Why?
| | Pupa | 1 | 2021 | 14 | 0.040 |
Why?
| | Inpatients | 1 | 2026 | 517 | 0.040 |
Why?
| | Protein Subunits | 1 | 2022 | 229 | 0.040 |
Why?
| | Mice, Inbred BALB C | 2 | 2016 | 1267 | 0.040 |
Why?
| | Argentina | 1 | 2020 | 29 | 0.040 |
Why?
| | Marsupialia | 1 | 2020 | 7 | 0.040 |
Why?
| | Rats | 2 | 2007 | 5585 | 0.040 |
Why?
| | Equidae | 1 | 2020 | 7 | 0.040 |
Why?
| | Chromogenic Compounds | 1 | 2020 | 4 | 0.040 |
Why?
| | Epitopes, B-Lymphocyte | 1 | 2020 | 19 | 0.040 |
Why?
| | Republic of Korea | 1 | 2020 | 42 | 0.040 |
Why?
| | Biomarkers | 2 | 2023 | 4207 | 0.040 |
Why?
| | Prepulse Inhibition | 1 | 2020 | 11 | 0.040 |
Why?
| | Writing | 1 | 2022 | 99 | 0.040 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2020 | 16 | 0.040 |
Why?
| | Geographic Mapping | 1 | 2020 | 27 | 0.040 |
Why?
| | Membrane Fusion | 1 | 2020 | 40 | 0.040 |
Why?
| | Genome Size | 1 | 2020 | 11 | 0.040 |
Why?
| | Yugoslavia | 1 | 2020 | 4 | 0.040 |
Why?
| | Ferrets | 1 | 2020 | 31 | 0.040 |
Why?
| | Cues | 1 | 2023 | 324 | 0.040 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2020 | 35 | 0.040 |
Why?
| | Psychotropic Drugs | 1 | 2021 | 76 | 0.040 |
Why?
| | Tissue Fixation | 1 | 2020 | 36 | 0.040 |
Why?
| | Rubella | 1 | 2020 | 23 | 0.040 |
Why?
| | Blotting, Western | 2 | 2014 | 1220 | 0.040 |
Why?
| | Paraffin Embedding | 1 | 2020 | 32 | 0.040 |
Why?
| | Pathology, Molecular | 1 | 2020 | 26 | 0.040 |
Why?
| | Blood Chemical Analysis | 1 | 2020 | 110 | 0.040 |
Why?
| | Apoptosis | 2 | 2019 | 2500 | 0.040 |
Why?
| | Host-Parasite Interactions | 1 | 2021 | 113 | 0.040 |
Why?
| | Formaldehyde | 1 | 2020 | 66 | 0.040 |
Why?
| | Diatoms | 1 | 2020 | 27 | 0.040 |
Why?
| | Transaminases | 1 | 2020 | 23 | 0.040 |
Why?
| | Fertility | 1 | 2021 | 165 | 0.040 |
Why?
| | Preoperative Period | 1 | 2020 | 144 | 0.040 |
Why?
| | Phosphorylation | 2 | 2014 | 1758 | 0.040 |
Why?
| | Injections, Subcutaneous | 1 | 2020 | 164 | 0.040 |
Why?
| | Codon | 1 | 2020 | 92 | 0.040 |
Why?
| | Haplotypes | 1 | 2021 | 491 | 0.040 |
Why?
| | Junin virus | 1 | 2019 | 1 | 0.040 |
Why?
| | Antibodies, Blocking | 1 | 2019 | 38 | 0.040 |
Why?
| | Reptiles | 1 | 2019 | 5 | 0.040 |
Why?
| | HeLa Cells | 2 | 2012 | 644 | 0.040 |
Why?
| | Electron Transport Complex III | 1 | 2019 | 19 | 0.040 |
Why?
| | Antigens, Viral | 1 | 2020 | 179 | 0.040 |
Why?
| | Prokaryotic Cells | 1 | 2019 | 6 | 0.040 |
Why?
| | Immunity, Innate | 1 | 2025 | 856 | 0.040 |
Why?
| | DNA, Bacterial | 1 | 2021 | 333 | 0.040 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2020 | 183 | 0.040 |
Why?
| | Convalescence | 1 | 2019 | 19 | 0.040 |
Why?
| | Erythrocebus | 1 | 2019 | 1 | 0.040 |
Why?
| | Asia, Western | 1 | 2019 | 5 | 0.040 |
Why?
| | Postoperative Period | 1 | 2020 | 360 | 0.040 |
Why?
| | Drosophila melanogaster | 1 | 2021 | 235 | 0.040 |
Why?
| | Endothelium, Vascular | 2 | 2019 | 951 | 0.040 |
Why?
| | U937 Cells | 1 | 2018 | 26 | 0.040 |
Why?
| | Cross-Over Studies | 1 | 2021 | 580 | 0.040 |
Why?
| | Viral Matrix Proteins | 1 | 2018 | 30 | 0.040 |
Why?
| | Analgesics | 1 | 2021 | 231 | 0.040 |
Why?
| | Fishes | 1 | 2019 | 110 | 0.040 |
Why?
| | Cyclin D1 | 1 | 2018 | 68 | 0.040 |
Why?
| | Sertoli Cells | 1 | 2018 | 29 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2006 | 1500 | 0.040 |
Why?
| | Transfection | 2 | 2011 | 936 | 0.040 |
Why?
| | Anesthetics, Dissociative | 1 | 2018 | 44 | 0.040 |
Why?
| | Acute Disease | 1 | 2021 | 1008 | 0.040 |
Why?
| | Metagenome | 1 | 2019 | 148 | 0.030 |
Why?
| | Purines | 1 | 2019 | 183 | 0.030 |
Why?
| | Injections, Intramuscular | 1 | 2018 | 141 | 0.030 |
Why?
| | Healthy Volunteers | 1 | 2019 | 213 | 0.030 |
Why?
| | Endocrine Glands | 1 | 2018 | 15 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2026 | 2980 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 573 | 0.030 |
Why?
| | Ethanol | 1 | 2023 | 637 | 0.030 |
Why?
| | Peripheral Nervous System | 1 | 2018 | 20 | 0.030 |
Why?
| | Tight Junctions | 1 | 2018 | 78 | 0.030 |
Why?
| | Sf9 Cells | 1 | 2017 | 10 | 0.030 |
Why?
| | Spodoptera | 1 | 2017 | 40 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 245 | 0.030 |
Why?
| | Child, Preschool | 2 | 2024 | 11634 | 0.030 |
Why?
| | Genitalia | 1 | 2018 | 34 | 0.030 |
Why?
| | Transcription Factors | 1 | 2006 | 1728 | 0.030 |
Why?
| | Machine Learning | 1 | 2023 | 567 | 0.030 |
Why?
| | RNA Editing | 1 | 2017 | 26 | 0.030 |
Why?
| | Epididymis | 1 | 2017 | 14 | 0.030 |
Why?
| | Exosomes | 1 | 2018 | 106 | 0.030 |
Why?
| | Autopsy | 1 | 2017 | 98 | 0.030 |
Why?
| | Databases, Genetic | 1 | 2018 | 246 | 0.030 |
Why?
| | Transcription, Genetic | 2 | 2016 | 1498 | 0.030 |
Why?
| | Poultry | 1 | 2017 | 11 | 0.030 |
Why?
| | Sample Size | 1 | 2017 | 126 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2018 | 4167 | 0.030 |
Why?
| | Drug Combinations | 1 | 2018 | 369 | 0.030 |
Why?
| | Databases, Factual | 1 | 2023 | 1458 | 0.030 |
Why?
| | Sex Ratio | 1 | 2017 | 15 | 0.030 |
Why?
| | Choice Behavior | 1 | 2019 | 172 | 0.030 |
Why?
| | Pilot Projects | 1 | 2023 | 1829 | 0.030 |
Why?
| | Glucose | 1 | 2022 | 1038 | 0.030 |
Why?
| | Blotting, Northern | 1 | 2017 | 200 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 350 | 0.030 |
Why?
| | Air Movements | 1 | 2016 | 10 | 0.030 |
Why?
| | Medical Waste Disposal | 1 | 2016 | 3 | 0.030 |
Why?
| | HSC70 Heat-Shock Proteins | 1 | 2016 | 4 | 0.030 |
Why?
| | Laboratory Personnel | 1 | 2016 | 4 | 0.030 |
Why?
| | Animal Welfare | 1 | 2016 | 16 | 0.030 |
Why?
| | Climate | 1 | 2017 | 89 | 0.030 |
Why?
| | Environment, Controlled | 1 | 2016 | 23 | 0.030 |
Why?
| | Equipment and Supplies | 1 | 2016 | 34 | 0.030 |
Why?
| | Nanopores | 1 | 2016 | 10 | 0.030 |
Why?
| | Nucleotide Motifs | 1 | 2016 | 36 | 0.030 |
Why?
| | Microscopy | 1 | 2018 | 156 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2018 | 772 | 0.030 |
Why?
| | Vitreous Body | 1 | 2017 | 122 | 0.030 |
Why?
| | Diamines | 1 | 2016 | 5 | 0.030 |
Why?
| | Geography | 1 | 2017 | 200 | 0.030 |
Why?
| | Lentivirus | 1 | 2016 | 59 | 0.030 |
Why?
| | Polysaccharides | 1 | 2016 | 88 | 0.030 |
Why?
| | Antibody-Dependent Enhancement | 1 | 2016 | 2 | 0.030 |
Why?
| | trans-Golgi Network | 1 | 2016 | 15 | 0.030 |
Why?
| | General Practice | 1 | 2016 | 32 | 0.030 |
Why?
| | Epidemics | 1 | 2017 | 95 | 0.030 |
Why?
| | Tidal Volume | 1 | 2016 | 106 | 0.030 |
Why?
| | Protein Conformation | 1 | 2019 | 941 | 0.030 |
Why?
| | Genetic Vectors | 1 | 2017 | 338 | 0.030 |
Why?
| | Benzothiazoles | 1 | 2016 | 41 | 0.030 |
Why?
| | Apathy | 1 | 2016 | 8 | 0.030 |
Why?
| | RNA, Satellite | 1 | 2015 | 1 | 0.030 |
Why?
| | Travel | 1 | 2017 | 143 | 0.030 |
Why?
| | Academies and Institutes | 1 | 2016 | 55 | 0.030 |
Why?
| | Coitus | 1 | 2015 | 23 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2021 | 832 | 0.030 |
Why?
| | Serogroup | 1 | 2015 | 45 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 2016 | 135 | 0.030 |
Why?
| | Cortical Synchronization | 1 | 2015 | 11 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2018 | 394 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2022 | 919 | 0.030 |
Why?
| | Medication Adherence | 1 | 2019 | 513 | 0.030 |
Why?
| | Unsafe Sex | 1 | 2015 | 63 | 0.030 |
Why?
| | Decision Making | 1 | 2022 | 957 | 0.030 |
Why?
| | Quinolines | 1 | 2016 | 171 | 0.030 |
Why?
| | Organic Chemicals | 1 | 2016 | 129 | 0.030 |
Why?
| | Topography, Medical | 1 | 2014 | 11 | 0.030 |
Why?
| | Motivation | 1 | 2019 | 606 | 0.030 |
Why?
| | Cognition | 1 | 2023 | 1249 | 0.030 |
Why?
| | Linear Models | 1 | 2017 | 857 | 0.030 |
Why?
| | Heart Rate | 1 | 2018 | 840 | 0.030 |
Why?
| | Protein Transport | 1 | 2016 | 446 | 0.030 |
Why?
| | Psychological Tests | 1 | 2015 | 133 | 0.030 |
Why?
| | Drug Resistance, Viral | 1 | 2015 | 122 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1496 | 0.030 |
Why?
| | Cohort Studies | 1 | 2024 | 5858 | 0.030 |
Why?
| | Acari | 1 | 2013 | 1 | 0.030 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 175 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2018 | 1254 | 0.030 |
Why?
| | Photic Stimulation | 1 | 2015 | 257 | 0.030 |
Why?
| | Signal Transduction | 2 | 2019 | 5163 | 0.030 |
Why?
| | Neurologic Examination | 1 | 2014 | 127 | 0.030 |
Why?
| | Actins | 1 | 2016 | 427 | 0.030 |
Why?
| | Hantaan virus | 1 | 2013 | 1 | 0.030 |
Why?
| | rab5 GTP-Binding Proteins | 1 | 2013 | 10 | 0.030 |
Why?
| | La Crosse virus | 1 | 2013 | 7 | 0.030 |
Why?
| | Adaptor Protein Complex 2 | 1 | 2013 | 11 | 0.020 |
Why?
| | Regression Analysis | 1 | 2016 | 1013 | 0.020 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2014 | 134 | 0.020 |
Why?
| | Chronic Disease | 1 | 2019 | 1815 | 0.020 |
Why?
| | Phenotype | 1 | 2021 | 3184 | 0.020 |
Why?
| | Diagnostic Tests, Routine | 1 | 2014 | 110 | 0.020 |
Why?
| | Cercopithecus | 1 | 2012 | 3 | 0.020 |
Why?
| | Mood Disorders | 1 | 2014 | 139 | 0.020 |
Why?
| | rab GTP-Binding Proteins | 1 | 2013 | 78 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2014 | 341 | 0.020 |
Why?
| | Vaccines, Virosome | 1 | 2012 | 1 | 0.020 |
Why?
| | Survival Analysis | 1 | 2015 | 1328 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2015 | 1364 | 0.020 |
Why?
| | Interferon-alpha | 1 | 2013 | 196 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2013 | 552 | 0.020 |
Why?
| | Genetic Markers | 1 | 2012 | 343 | 0.020 |
Why?
| | Prognosis | 1 | 2020 | 4112 | 0.020 |
Why?
| | Risk Factors | 1 | 2026 | 10593 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2011 | 117 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 469 | 0.020 |
Why?
| | Social Behavior | 1 | 2014 | 289 | 0.020 |
Why?
| | Middle East | 1 | 2011 | 18 | 0.020 |
Why?
| | Small Molecule Libraries | 1 | 2012 | 104 | 0.020 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 1 | 2011 | 25 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1977 | 0.020 |
Why?
| | Bone Marrow Stromal Antigen 2 | 1 | 2010 | 11 | 0.020 |
Why?
| | Cytokines | 1 | 2019 | 2093 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2011 | 345 | 0.020 |
Why?
| | High-Throughput Screening Assays | 1 | 2012 | 158 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1353 | 0.020 |
Why?
| | Research Design | 1 | 2017 | 1113 | 0.020 |
Why?
| | GPI-Linked Proteins | 1 | 2010 | 78 | 0.020 |
Why?
| | Europe | 1 | 2011 | 410 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 2012 | 622 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2014 | 521 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2010 | 334 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2020 | 5967 | 0.020 |
Why?
| | Iron Metabolism Disorders | 1 | 2008 | 6 | 0.020 |
Why?
| | Structural Homology, Protein | 1 | 2008 | 26 | 0.020 |
Why?
| | Monomeric GTP-Binding Proteins | 1 | 2008 | 14 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2016 | 2828 | 0.020 |
Why?
| | Risk Assessment | 1 | 2017 | 3562 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2008 | 120 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2009 | 309 | 0.020 |
Why?
| | Inflammation | 1 | 2019 | 2867 | 0.020 |
Why?
| | Tyrosine | 1 | 2008 | 229 | 0.020 |
Why?
| | Emigration and Immigration | 1 | 2007 | 58 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2011 | 1185 | 0.020 |
Why?
| | Culture Media | 1 | 2007 | 163 | 0.020 |
Why?
| | Age of Onset | 1 | 2008 | 545 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2927 | 0.010 |
Why?
| | Mass Spectrometry | 1 | 2009 | 738 | 0.010 |
Why?
| | Viverridae | 1 | 2005 | 1 | 0.010 |
Why?
| | Antibodies | 1 | 2007 | 400 | 0.010 |
Why?
| | Iron | 1 | 2007 | 338 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1773 | 0.010 |
Why?
| | Catalytic Domain | 1 | 2005 | 224 | 0.010 |
Why?
| | Incidence | 1 | 2011 | 2826 | 0.010 |
Why?
| | Asia, Central | 1 | 2003 | 1 | 0.010 |
Why?
|
|
Kuhn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|